We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Fibrocell Science Inc. in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 22 → 0 (-22)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $10.6M → $0 (-$10.6M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 22

Holders
–
Holders Change
-22
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TS
Third Security
Virginia
-$4.89M
2
Renaissance Technologies
Renaissance Technologies
New York
-$2.26M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1.17M
4
BCM
Beryl Capital Management
California
-$883K
5
MP
MSD Partners
New York
-$410K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
– -$4.89M -1,653,486 Closed
Renaissance Technologies
2
Renaissance Technologies
New York
– -$2.26M -763,754 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$1.17M -395,626 Closed
BCM
4
Beryl Capital Management
California
– -$883K -298,279 Closed
MP
5
MSD Partners
New York
– -$410K -138,592 Closed
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
– -$317K -107,069 Closed
Geode Capital Management
7
Geode Capital Management
Massachusetts
– -$287K -97,043 Closed
Morgan Stanley
8
Morgan Stanley
New York
– -$148K -49,900 Closed
Creative Planning
9
Creative Planning
Kansas
– -$40K -13,402 Closed
Cambridge Investment Research Advisors
10
Cambridge Investment Research Advisors
Iowa
– -$37K -12,618 Closed
SMC
11
S. Muoio & Co
New York
– -$35K -11,590 Closed
Northern Trust
12
Northern Trust
Illinois
– -$32K -10,882 Closed
BlackRock
13
BlackRock
New York
– -$25K -8,318 Closed
Deutsche Bank
14
Deutsche Bank
Germany
– -$19K -6,600 Closed
UBS Group
15
UBS Group
Switzerland
– -$19K -6,253 Closed
Wells Fargo
16
Wells Fargo
California
– -$7K -2,568 Closed
ADL
17
Asset Dedication LLC
California
– -$6K -2,002 Closed
Victory Capital Management
18
Victory Capital Management
Texas
– -$4K -1,442 Closed
Bank of America
19
Bank of America
North Carolina
– -$1K -395 Closed
RE
20
RBC Europe
United Kingdom
– -$41 -14 Closed
BNP Paribas Financial Markets
21
BNP Paribas Financial Markets
France
– -$3 -1 Closed

FCSC Hedge Fund Activity: Q4 2019 in Review

0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2019, worth a combined $0 — down 100% from $10.6M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of FCSC and 0 opened new positions — a net loss of 22 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Third Security, exiting entirely with an estimated $4.89M sold.

  • 0 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2019, down from 22 in Q3 2019.
  • Funds reported $0 of Fibrocell Science Inc. stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Fibrocell Science Inc. positions in Q4 2019 and 22 closed out, a net change of -22 holders.
  • The largest Fibrocell Science Inc. seller in Q4 2019 was Third Security, an estimated $4.89M sold.

Based on aggregated 13F filings for Q4 2019.